In Vivo regulation of Oligodendrocyte processor cell proliferation and differentiation by the AMPA-receptor Subunit GluA2 by Chen, Ting et al.
ReportIn Vivo Regulation of Oligodendrocyte Precursor Cell
Proliferation and Differentiation by the AMPA-
Receptor Subunit GluA2Graphical AbstractHighlightsd AMPA receptors (AMPARs) with modified properties are
expressed in OPCs in vivo
d Channel-pore mutations of AMPARs affect functional
properties of axon-OPC synapses
d Expression of Ca2+-permeable AMPARs alters proliferation
and differentiation of OPCs
d Introducing the C-tail of the GluA2 subunit of AMPARs
reduces differentiation of OPCsChen et al., 2018, Cell Reports 25, 852–861
October 23, 2018 ª 2018
https://doi.org/10.1016/j.celrep.2018.09.066Authors
Ting-Jiun Chen, Bartosz Kula,
Ba´lint Nagy, Ruxandra Barzan,
Andrea Gall, Ingrid Ehrlich, Maria Kukley
Correspondence
maria.kukley@uni-tuebingen.de
In Brief
In the brain, oligodendrocyte precursor
cells (OPCs) receive glutamatergic
AMPA-receptor-mediated synaptic input
from neurons. Chen et al. show that
modifying AMPA-receptor properties at
axon-OPC synapses alters proliferation
and differentiation of OPCs. This expands
the traditional view of synaptic
transmission by suggesting neurons also
use synapses to modulate behavior of
glia.
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The functional role of AMPA receptor (AMPAR)-
mediated synaptic signaling between neurons and
oligodendrocyte precursor cells (OPCs) remains
enigmatic. We modified the properties of AMPARs
at axon-OPCsynapses in themouse corpus callosum
in vivo during the peak of myelination by targeting
the GluA2 subunit. Expression of the unedited (Ca2+
permeable) or the pore-dead GluA2 subunit of
AMPARs triggeredproliferation ofOPCsand reduced
their differentiation into oligodendrocytes. Ex-
pression of the cytoplasmic C-terminal (GluA2(813-
862)) of the GluA2 subunit (C-tail), a modifica-
tion designed to affect the interaction between
GluA2 and AMPAR-binding proteins and to
perturb trafficking of GluA2-containing AMPARs,
decreased the differentiation of OPCs without
affecting their proliferation. These findings suggest
that ionotropic and non-ionotropic properties of
AMPARs in OPCs, as well as specific aspects of
AMPAR-mediated signaling at axon-OPC synapses
in the mouse corpus callosum, are important for
balancing the response of OPCs to proliferation and
differentiation cues.INTRODUCTION
In the CNS, neurons are involved in glutamatergic synaptic
signaling with oligodendrocyte precursor cells (OPCs). At these
neuron-glia synapses, action potentials trigger a fast vesicular
release of the neurotransmitter glutamate, which binds to
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-852 Cell Reports 25, 852–861, October 23, 2018 ª 2018
This is an open access article under the CC BY-NC-ND license (http://tors (AMPARs) on the OPCs and leads to the activation of a de-
polarizing current (Bergles et al., 2000). Axon-OPC synapses are
present in gray matter and white matter areas of rodent brain
(Fro¨hlich et al., 2011) and human brain (Gallo et al., 2008), but
their functional role remains a puzzle. Proliferation and differen-
tiation of OPCs, as well as myelination, are influenced by
neuronal activity (Mount and Monje, 2017). Because axon-OPC
synapses represent the points of direct structural and functional
interaction between the two cell types, they are ideal sites at
which the effects of neuronal activity can be conveyed to glial
cells. As a consequence, genetic disruption of axon-OPC synap-
ses is expected to affect proliferation or differentiation of OPCs
or myelination. However, a study showed that although perma-
nent deletion of AMPARs in OPCs from the onset of mouse
development reduced axon-OPC synaptic signaling, it did not
alter proliferation and differentiation of OPCs but instead facili-
tated apoptotic death of oligodendrocytes (OLs) (Kougioumtzi-
dou et al., 2017). In the present study, we used a different strat-
egy to investigate the functional role of axon-OPC synaptic
signaling: we aimed at perturbation of the properties of postsyn-
aptic AMPARs inOPCs, rather than at perpetual deletion of these
receptors.
AMPARs are large macromolecular complexes that in neu-
rons comprise more than 30 proteins (Schwenk et al., 2014).
The core of the AMPAR complex is a tetramer of GluA1–
GluA4 subunits, which assemble in different combinations
to form a channel pore. The GluA2 subunit is key, because it
determines the single-channel conductance (Swanson et al.,
1997) and the Ca2+ permeability of AMPARs (Hume et al.,
1991). Deletion or modification of the GluA2 subunit in neurons
results in strong alterations of synaptic function and animal
development (Isaac et al., 2007). We expressed the full-
length receptors with point mutations in the GluA2 subunit,
or the truncated GluA2 subunit, in OPCs in vivo and assessed
the effects on physiology and function of the oligodendroglial
cells.creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Retroviral Infection Specifically
Targets Oligodendroglia Lineage Cells
(A) Scheme of the recombinant retroviral vector.
The cytomegalovirus promoter (P-CMV) drives
transcription of the viral genome; the chicken-beta
actin (CAG) promoter drives expression of GFP.
LTR, long terminal repeat; J, viral packing signal;
WPRE, Woodchuck hepatitis virus post-tran-
scriptional regulatory element.
(B) Experimental design and timeline. IHC, immu-
nohistochemistry.
(C) Representative images of coronal brain slices
stained for myelin basic protein (red). P9, P10,
P11, P12, P15, and P18 indicate postnatal days at
which slices were prepared. Dashed lines indicate
borders of each slice. Arrowheads point to the
midline of the corpus callosum. Scale bar: 1 mm.
(D) Stereotaxic coordinates for bilateral virus
injection into the corpus callosum. AP, ante-
roposterior; ML, mediolateral; DV, dorsoventral.
(E) Scheme showing distribution of cells infected
with retrovirus (GFP+ cells, green dots) in the
corpus callosum. GFP+ cells were found in
several 300-mm-thick coronal slices along the
rostro-caudal axis.
(F) Maximum intensity projection (6 successive
confocal planes) showing GFP+ cells in the corpus
callosum (yellow dashed line). Scale bar: 100 mm.
(G) Most GFP+ cells belong to the oligodendroglia
lineage (n = 8 animals). OPCs, oligodendrocyte
precursor cells; pre-OLs, pre-myelinating oligo-
dendrocytes; OLs, oligodendrocytes.
(H) Maximum intensity projection (3 successive
confocal planes) showing quadruple labeling for
DAPI, GFP, NG2, CC1, and themerged image. The
arrowhead points to an OPC (GFP+NG2+CC1).
Stitches visible in all panels at highermagnification
appeared because images have been acquired
as multiple tile scans, and the edges of two
neighboring tiles have not been stitched properly
by the software. Scale bar: 10 mm.
(I) As in (H), but the arrowhead points to a pre-OL
(GFP+NG2+CC1+).
(J) As in (H) and (I), but the arrowhead points to an
OL (GFP+NG2CC1+).RESULTS
Experimental Strategies for Modifying the
GluA2-Containing AMPARs in OPCs In Vivo
We perturbed the properties of GluA2-containing AMPARs in
OPCs in the corpus callosum during the second and third post-Cell Rnatal weeks in mice (Figures 1A, 1B, and
2A–2C), when the OPC division rate is
high (Moshrefi-Ravasdjani et al., 2017)
and many OPCs differentiate into myeli-
nating OLs, which is reflected in a steep
increase of myelin basic protein expres-
sion (Figure 1C). The edited GluA2 sub-
unit is present in callosal OPCs during
this time window, because the current-
voltage (I-V) relationship of AMPAR-mediated excitatory postsynaptic currents (EPSCs) in OPCs
shows only slight inward rectification, with an average rectifica-
tion index (RI) of 0.33 ± 0.058 (Figures S1A and S1B).
To target AMPARs specifically in OPCs, we used a retroviral
gene delivery approach (Tashiro et al., 2006) and performed
three manipulations (Figures 2A and 2B), which are welleports 25, 852–861, October 23, 2018 853
Figure 2. Modifications of the GluA2 Sub-
unit of AMPARs in OPCs Change Rectifica-
tion and Amplitude of Axon-Glia EPSCs
(A) Scheme of the GluA2 subunit of AMPARs
with a Q/R editing site. Q, glutamine; R, arginine;
TM, transmembrane domain; N, N terminus; C,
C terminus.
(B) Scheme of the mutated and truncated GluA2
subunits fused to GFP and expressed by the viral
vector. Amino acid 583 is the site of the point
mutation.
(C) Experimental design and timeline for electro-
physiological experiments.
(D) Examples of current-voltage (I-V) relationships
of evoked EPSCs in OPCs infected with retrovirus
expressing GFP or AMPAR-modifying constructs.
Black dots represent the average amplitudes of 10
sweeps recorded at each holding potential (Vh).
Corresponding averaged sweeps are shown
above. Arrowheads indicate time of stimulation;
stimulation artifacts are blanked for clarity.
(E) Rectification index (RI) for evoked EPSCs
in OPCs infected with retrovirus expressing GFP
(n = 12 cells/9 mice), Ca2+-permeable (n = 8 cells/7
mice), pore-dead (n = 6 cells/6 mice), or C-tail
(n = 8 cells/6 mice) constructs. Colored dots
represent individual cells; black diamonds repre-
sent group mean ± SEM. The dashed line indicates
the theoretical RI for a linear I-V relationship (0.44).
One-way ANOVA (F(3, 30) = 11.800, p = 0.000028)
with post hoc Games-Howell test: GFP versus
Ca2+ permeable, ***p = 0.001; GFP versus pore
dead, **p = 0.002; GFP versus C-tail, p = 0.969.
(F) Representative example traces of delayed
EPSCs recorded after cessation of train stimula-
tion in OPCs infected with retrovirus expressing
GFP or AMPAR-modifying constructs (Vhold =
80 mV). Stars indicate delayed EPSCs; blue stars
indicate events shown on the right.
(G) Averaged delayed EPSCs from OPCs ex-
pressing GFP (7 cells), Ca2+-permeable (7 cells),
pore-dead (8 cells), and C-tail (8 cells) constructs.
In each cell, 67 events were randomly selected and
averaged. Subsequently, the averages from all
cells per group were pooled to generate the
average EPSCs.
(H) Cumulative probability distribution of EPSC
amplitudes obtained by pooling 67 randomly
selected events from each cell within each exper-
imental group. GFP, 469 events (n = 7 cells/6mice);
Ca2+ permeable, 469 events (n = 7 cells/6 mice);
pore dead, 536 events (n = 8 cells/6 mice); C-tail,
536 events (n = 8 cells/6 mice). Kolmogorov-
Smirnov test: GFP versus Ca2+ permeable, ***p = 0.00000013492; GFP versus pore dead, ***p = 0.000006; GFP versus C-tail, p = 0.101.
(I) Representative examples of variance-mean plots with parabola fit (red line) for delayed EPSCs recorded in OPCs expressing GFP or AMPAR-modifying
constructs. The analysis is based on 85 events in each group. g is the single-channel conductance estimated from the parabola fit.
(J) Average single-channel conductance (mean ± SEM) of synaptic AMPARs in OPCs expressing GFP or AMPAR-modifying constructs. Red numbers in the bar
graphs indicate the average percentage values of single-channel conductance for different manipulations of AMPARs compared to the GFP group (100%, red
dashed line).
(K) Estimation of the fraction of rectifying AMPARs (FRR) based on rectification measurements. Open circles and the black curve represent the model for
measurements. Colored dots represent values of FRR corresponding to 1/RI (mean ± SEM) for GFP and AMPAR-modifying constructs.characterized in neurons (Hayashi et al., 2000; Shi et al., 2001):
(1) expression of the unedited GluA2(R583Q)-GFP subunit
(Ca2+-permeable), aiming to create exclusively Ca2+-permeable
AMPARs by replacing arginine(R)583 with glutamine(Q) (Hume854 Cell Reports 25, 852–861, October 23, 2018et al., 1991) at the channel pore; (2) expression of the
GluA2(R583E)-GFP subunit (pore-dead), aiming to reduce the
number of functional GluA2-containing AMPARs by replacing
arginine(R)583 with glutamic acid(E) in the channel pore
(Dingledine et al., 1992; Shi et al., 2001); and (3) overexpression
of the cytoplasmic C-terminal (GluA2(813-862)) of GluA2 (C-tail),
a soluble polypeptide of 50 amino acids that in neuronsmediates
trafficking of receptors to the membrane and interaction with
other proteins within the AMPAR complex (Henley, 2003). The
C-tail was expected to perturb trafficking of endogenous
AMPAR in OPCs (Bassani et al., 2009; Shi et al., 2001). Each
construct was tagged with GFP (Figure 2B) to identify infected
cells. Recombinant retroviral vectors expressing GFP (control)
(Figure 1A) or one of the constructs were stereotaxically injected
into the corpus callosum of postnatal day (P) 10–P12 mice (Fig-
ures 1B and 1D).
The Retroviral Vector Specifically Targeted
Oligodendroglia Lineage Cells
To verify that retroviral vectors specifically targeted OPCs, we
counted oligodendroglia lineage cells positive for neuron-glia-
antigen-2 (NG2) or adenomatous polyposis coli (APC/CC1)
5 days after injection of the GFP-expressing retrovirus (Figures
1E–1J). 94% of the GFP+ cells were oligodendroglial cells:
33.35% ± 3.3% were GFP+NG2+CC1 OPCs, 17.4% ± 3.6%
were GFP+NG2+CC1+ pre-myelinating OLs (pre-OLs), and
43.2% ± 4.2% were GFP+NG2CC1+ mature OLs (Figures
1E–1J). Cells considered pre-OLs in our study are likely earlier
pre-OLs than ENPP6+ cells (Xiao et al., 2016), because the latter
do not label for platelet-derived growth factor receptor alpha
(PDGFRa).
Most GFP+NG2+ cells were not pericytes: 90% of them were
located away from blood vessels and showed a rich tree of pro-
cesses typical for OPCs (Bergles et al., 2000; Kukley et al., 2007),
8% were in the vicinity of a blood vessel but possessed dichot-
omized processes, and only 2% were near a blood vessel, had
no or few processes (Figures S2A–S2G), and could be pericytes.
Thus, our retroviral vectors specifically and efficiently targeted
oligodendroglia lineage cells in vivo.
Pore Mutations of the GluA2 Subunit in OPCs Changed
Rectification and Amplitude of Axon-Glia EPSCs
Trafficking of full-length AMPARs to the cell surface and integra-
tion into the cell membrane are important prerequisites for their
delivery to synaptic sites (Borgdorff andChoquet, 2002; Derkach
et al., 2007). To verify that receptors with Ca2+-permeable and
pore-dead GluA2 subunits were targeted to the cell membrane
of OPC, we immunolabeled the GFP fused to the N-terminal
domain of the mutant GluA2 subunits (Figure S3A), without cell
permeabilization (Kopec et al., 2006). GFP immunoreactivity
was localized exclusively to the cell membrane and processes
of OPCs (Figures S3B and S3C), confirming that mutant subunits
were inserted into the membrane, from which they could be re-
cruited to synapses by lateral diffusion. We did not assess this
for the C-tail, because it is not a transmembrane protein.
To investigate changes in Ca2+ permeability of AMPARs at
axon-OPC synapses, we studied the I-V relationship of evoked
EPSCs in NG2DsRed+GFP+ OPCs recorded in whole-cell,
voltage-clampmode. In each experiment, we verified that the re-
corded cell had an electrophysiological signature of OPCs (Fig-
ure S2H) (Kukley et al., 2010) and was not a pericyte (Kawamura
et al., 2002). The I-V relationship of EPSCs in OPCs expressingthe GluA2(R583Q)-GFP showed marked inward rectification
(RI = 0.093 ± 0.018) (Figures 2D and 2E), as expected for Ca2+-
permeable AMPARs (Verdoorn et al., 1991). This suggests that
modified GluA2 subunits assembled into tetrameric receptors,
trafficked to the postsynaptic sites of axon-OPC synapses,
and replaced the endogenous AMPARs. Clear inward rectifica-
tion (RI = 0.078 ± 0.034) (Figures 2D and 2E) was also observed
in OPCs expressing GluA2(R583E)-GFP, indicating that synaptic
AMPARs lacked the conducting GluA2 subunit and were Ca2+
permeable. The expression of the C-tail did not alter the I-V rela-
tionship (RI = 0.38 ± 0.054) (Figures 2D and 2E), suggesting
that the delivery of endogenous GluA2-containing AMPARs to
synaptic sites was unaffected. To quantify changes of AMPAR
properties, we adopted a model for estimating the fraction of
rectifying Ca2+-permeable receptors (Stubblefield and Benke,
2010). More than 95% of synaptic AMPARs were rectifying in
OPCs expressing the Ca2+-permeable or pore-dead construct,
but only 40.18% ± 0.5% and 29.44% ± 0.47% were rectifying
in GFP- and C-tail-expressing OPCs, respectively (Figure 2K).
To estimate alterations in the strength of individual axon-OPC
synapses, we analyzed the amplitude of quantal EPSCs in OPCs
(Nagy et al., 2017) (Figure 2F). The expression of Ca2+-perme-
able and pore-dead constructs shifted the cumulative histogram
toward larger current amplitudes when compared to the GFP
group (Figures 2G and 2H) and increased the single-channel
conductance of synaptic AMPARs (Figures 2I and 2J). A larger
single-channel conductance is expected for AMPARs lacking
the functional (edited) GluA2 subunit (Swanson et al., 1997), is
in line with the inwardly rectifying I-V relationship (Figures 2D
and 2E), and likely underlies the increase in the current ampli-
tude. However, this result differed from that of pyramidal neu-
rons, in which expression of the pore-dead construct reduced
the EPSC amplitude (Shi et al., 2001). It is possible that in neu-
rons, AMPARs with pore-dead GluA2 subunits merely replaced
endogenous receptors, while in OPCs, the integration of pore-
dead subunits was accompanied by insertion of additional func-
tional GluA2-lacking AMPARs. Expression of the C-tail did not
affect the quantal EPSC amplitude and single-channel conduc-
tance of AMPARs (Figures 2G–2J). Together with the unchanged
RI (Figures 2D and 2E), this suggests that the C-tail did not alter
the ionotropic function of AMPARs at axon-OPC synapses.
None of the constructs affected presynaptic properties of
axon-OPC synapses, because the paired-pulse ratio (PPR) of
evoked EPSCs, a parameter reflecting alterations in neurotrans-
mitter release probability (Dobrunz and Stevens, 1997), was un-
changed (Figures S3D and S3E). Retroviral infection also did not
modify presynaptic release probability or the number and Ca2+
permeability of postsynaptic AMPARs in OPCs (Figure S1).
All Manipulations of the GluA2 Subunit Altered the
Fraction of OPCs and OLs within the Oligodendroglia
Lineage
To investigate changes in OPC differentiation, we counted
OPCs, pre-OLs, and mature OLs labeled with specific molecular
markers 5 days after the viral injection (Figures 3A–3D). The
fraction of OPCs was larger in animals expressing the GluA2
subunit with pore mutations than in the GFP group (Figure 3E),
while the proportion of OLs was lower (Figure 3G), suggestingCell Reports 25, 852–861, October 23, 2018 855
Figure 3. Modifications of the GluA2 Sub-
unit of AMPARs in OPCs Decrease OPC
Differentiation
(A) Scheme of the differentiation process in the
oligodendroglia lineage.
(B) Maximum intensity projection (3 successive
confocal planes) showing examples of OPC
(GFP+NG2+CC1) infected with retrovirus ex-
pressing the pore-dead construct. Colors are
as in Figures 1H–1J. Arrows point to the soma of
infected cells. Scale bar: 10 mm.
(C) As in (B), but for a pre-myelinating oligoden-
drocyte (GFP+NG2+CC1+).
(D) As in (B) and (C), but for an oligodendrocyte
(GFP+NG2CC1+).
(E) Percentage of OPCs (GFP+ NG2+CC1) among
the GFP+ cells expressing GFP (n = 8), Ca2+-
permeable (n = 7), pore-dead (n = 8), and C-tail
(n = 9) constructs. Colored dots represent indi-
vidual animals; black diamonds represent group
mean ± SEM. One-way ANOVA (F(3, 28) = 15.175,
p = 0.000005) with post hoc Bonferroni test:
GFP versus Ca2+-permeable, ***p = 0.000008;
GFPversuspore-dead, ***p=0.000143;GFPversus
C-tail, ***p = 0.000146; Ca2+-permeable versus
pore-dead, p = 1.000; Ca2+-permeable versus
C-tail, p = 1.000; pore-dead versusC-tail, p = 1.000.
(F)As in (E),but forpre-myelinatingoligodendrocytes
(GFP+NG2+CC1+). One-way ANOVA (F(3, 28) =
0.077, p = 0.972).
(G) As in (E) and (F), but for oligodendrocytes
(GFP+NG2CC1+). One-way ANOVA (F(3, 28) =
15.557, p = 0.000004) with post hoc Bonferroni
test: GFP versus Ca2+-permeable, ***p =
0.000006; GFP versus pore-dead, ***p = 0.000085;
GFP versus C-tail, ***p = 0.000253; Ca2+-perme-
able versus pore-dead, p = 1.000; Ca2+-perme-
able versus C-tail, p = 0.581; pore-dead versus C-
tail, p = 1.000.
(H) Maximum intensity projection (3 successive
confocal planes) showing examples of MAG+
oligodendrocytes (arrowheads) in an animal in-
fected with retrovirus expressing GFP. Scale bar:
10 mm.
(I) As in (H), but for the Ca2+-permeable construct.
(J) As in (H) and (I), but for the pore-dead construct.
(K) As in (H)–(J), but for the C-tail construct.
(L) Proportion of GFP+NG2MAG+ cells among
the GFP+ cells expressing GFP (n = 3 mice),
Ca2+-permeable (n = 3 mice), pore-dead (n = 3
mice), and C-tail (n = 3 mice) constructs. Each
dot represents one animal; black diamonds
represent mean ± SEM for each group. One-
way ANOVA (F(3, 8) = 43.234, p = 0.000027)
with post hoc Dunnett’s test: GFP versus Ca2+-
permeable, ***p = 0.000023; GFP versus pore-
dead, ***p = 0.000057; GFP versus C-tail,
***p = 0.000052.that differentiation of OPCs into OLs was reduced. There was no
difference in the percentage of pre-OLs between the groups
(Figure 3F). The reduction in OPC differentiation was confirmed
by counting the mature OLs expressing myelin-associated856 Cell Reports 25, 852–861, October 23, 2018glycoprotein (MAG). The proportion of GFP+NG2MAG+ cells
among GFP+ cells was lower in animals expressing the GluA2
subunits with pore mutations than in the GFP group (Figures
3H–3L).
Expression of the C-tail increased the fraction of OPCs and
reduced the fraction of OLs within the GFP+ population (Figures
3E–3L). This was surprising, because in contrast to pore muta-
tions, the C-tail did not alter the ionotropic function of AMPARs.
It is possible that OPC differentiation was affected because the
C-tail interfered with AMPAR signaling via intracellular binding
partners of the GluA2 subunit.
The decrease in the fraction of OLs was not a consequence
of cell death, because an apoptotic marker, activated cas-
pase-3, was hardly detected in the corpus callosum (Figures
S3F–S3K). It was also not a consequence of OPC differentiation
into other cell types, because the fraction of oligodendroglia
lineage cells within the GFP+ population was comparable in all
groups (Figures 3E–3G).
Thus, manipulations of the GluA2 subunit in callosal OPCs
perturb normal differentiation of OPCs into OLs.
Pore Mutations of the GluA2-Containing AMPARs
Increase Proliferation of OPCs
During the second and third postnatal weeks in mice, many
OPCs are actively cycling. Therefore, an increase in the fraction
of OPCs (Figure 3E) may be attributable to continued cycling of
OPCs at the expense of differentiation (Figure 4A). To test this,
we compared the fraction of proliferating GFP+ cells in mice ex-
pressing the GFP versus mice expressing the modified GluA2
subunits, or the C-tail. We used two approaches: (1) in vivo label-
ing with 5-ethynyl-20-deoxyuridine (EdU), which integrates dur-
ing the S phase, and (2) ex vivo labeling for Ki67, which is present
during all active phases of the cell cycle (Gerdes et al., 1984).
Pore mutations altering the Ca2+ permeability of AMPARs in
OPCs resulted in a larger proportion of cycling cells (GFP+EdU+)
(Figures 4B and 4C). This was caused by an increase in EdU+
OPCs, because the GFP+ population contained a higher per-
centage of NG2+EdU+ cells (Figure 4D). In addition, most EdU+
cells were NG2+ in all groups (not shown), indicating that neither
of the AMPAR manipulations specifically triggered fast differen-
tiation of EdU+ OPC into OLs.
With our retroviral approach, we initially targeted cycling OPCs
(Yamashita and Emerman, 2006). Therefore, the GFP+ popula-
tion represents cells that are progressing through or have
recently completed the cell cycle. EdU injected 3–5 days after
the retroviral infection incorporates only into newly synthesized
DNA. Therefore, GFP+EdU+ cells denote cells that continued
cycling, passed through the S phase again, and underwent
another cell division after retroviral infection. An enhanced frac-
tion of EdU+NG2+ cells within GFP+ population upon alteration of
Ca2+ permeability of AMPARs (Figure 4D) indicates that poremu-
tations of GluA2 subunit prompted OPCs to re-enter mitosis. If
increased Ca2+ permeability of AMPARs triggers cell division,
but does not promote differentiation, then the population of
GFP+NG2+ cells should contain a higher proportion of EdU+
cells. This was only observed for the pore-dead mutation, not
the Ca2+-permeable mutation (Figure 4E), suggesting that the
former promoted proliferation of OPCs more effectively than
the latter. In accordance with this, labeling for Ki67 on the 5th
day after viral infection in animals treated with EdU (Figure 4F)
showed that the proportion of still-cycling OPCs (GFP+NG2+
EdU+Ki67+) within the population of previously cycling OPCs(GFP+NG2+EdU+) was increased only upon expression of the
pore-dead mutation (Figure 4G).
Expression of the C-tail did not alter OPC proliferation (Figures
4C–4E and 4G). Therefore, one might expect that the proportion
of OPCs is lower after introducing the C-tail than after intro-
ducing the GluA2 pore mutations. But this was not the case (Fig-
ure 3E), and there was no difference in apoptotic cell death be-
tween the manipulations (Figures S3F–S3K). Two mechanisms
may underlie an increase in the OPC population: (1) OPCs cycle,
rather than differentiate, or (2) OPCs stay longer in the G1 phase
or exit the cell cycle but do not differentiate at the usual rate
(Figure 4A). When combining the data on differentiation (Figures
3E–3G) and proliferation (Figures 4C–4E and 4G) into a unified
model (Figure 4H; Figure S4), we found that EdU+ and EdU
OPCs contributed to increasing the population of GFP+NG2+
cells for all manipulations (Figure 4H). However, for the pore-
dead construct, the fraction of EdU+ OPCs was higher than the
fraction of EdU OPCs; for the C-tail, the opposite was true;
and for the Ca2+-permeable construct, the contribution of those
two populations was roughly equal (Figure 4H). This indicates
that bothmechanisms play a role but that their impact is different
depending on the properties of AMPARs. Therefore, axon-OPC
synapses are likely involved in regulating the ratio between
cycling and non-cycling OPCs.
DISCUSSION
Our major finding is that manipulating the key properties of
AMPARs at axon-OPC synapses in vivo at the peak of myelina-
tion results in altered balance between proliferation and differen-
tiation of OPCs.
In cell culture, AMPARs regulate proliferation and differentia-
tion of OPCs (Fannon et al., 2015; Gallo et al., 1996; Hossain
et al., 2014; Yuan et al., 1998), and Ca2+-permeable AMPARs
indirectly modulate the expression of genes involved in differen-
tiation and growth (Pende et al., 1994). Ca2+ ions are important
modulators of proliferation and differentiation of many cells,
including neuronal progenitors and tumor and endothelial cells
(Cui et al., 2017; Jansson and A˚kerman, 2014; Moccia et al.,
2012). Our findings in vivo suggest that Ca2+ permeability of
AMPARs may be a key mechanismmodulating the development
of oligodendroglial cells. During the second and third postnatal
weeks inmice, when extensivemyelination of axons takes place,
OPCs efficiently respond to proliferation and differentiation cues,
but it is unknown how OPCs make the choice between the
two processes. In GFP controls and in non-injected mice, the
RI was highly variable, ranging from 0.15 to 0.68 (Figure 2E; Fig-
ure S1B). Hence, during normal development, some OPCs have
higher Ca2+ permeability of AMPARs than others. Possibly,
OPCs with high Ca2+ permeability of AMPARs continue cycling,
while OPCs with low Ca2+ permeability of AMPARs are prone to
differentiate. This is also suggested by a study showing that
AMPARs in differentiating OPCs have lower Ca2+ permeability
than in immature OPCs (Zonouzi et al., 2011). Thus, Ca2+ perme-
ability of AMPARs is likely a physiological mechanism regu-
lating the choice between proliferation and differentiation of
OPCs. Another mechanism may be the subunit composition of
AMPARs. We found that the pore-dead mutation of the GluA2Cell Reports 25, 852–861, October 23, 2018 857
Figure 4. Modifications Rendering AMPARs Ca2+ Permeable Increase OPC Proliferation
(A) Scheme illustrating that OPCs infected with retrovirus can follow different developmental fates. Cells with a red nucleus indicate EdU+ cells. IHC, immu-
nohistochemistry.
(B) Maximum intensity projection (2 successive confocal planes) showing examples of quadruple labeling for DAPI (blue), GFP (green), EdU (white), and NG2 (red)
and a merged image in animals expressing the GFP, Ca2+-permeable, pore-dead, or C-tail construct. White arrowheads mark GFP+NG2+EdU+ cells. Scale bar:
10 mm.
(C) Proportion of GFP+EdU+ cells among the GFP+ cells expressing the GFP (n = 8 mice), Ca2+-permeable (n = 7 mice), pore-dead (n = 8 mice), and C-tail (n = 8
mice) constructs. Colored dots represent individual animals; black diamonds represent group mean ± SEM. One-way ANOVA (F(3, 27) = 14.234, p = 0.000009)
with post hoc Dunnett’s test: GFP versus Ca2+-permeable, ***p = 0.001; GFP versus pore-dead, ***p = 0.000004; GFP versus C-tail, p = 0.074.
(D) As in (C), but for the proportion of GFP+NG2+EdU+ among the GFP+ cells. Kruskal-Wallis test (H(3) = 21.277, p = 0.000092) with post hoc Dunn’s test: GFP
versus Ca2+-permeable, **p = 0.009; GFP versus pore-dead, ***p = 0.000084; GFP versus C-tail, p = 0.499.
(E) As in (C) and (D), but for the proportion of GFP+NG2+EdU+ cells among the GFP+NG2+ cells. One-way ANOVA (F(3, 27) = 5.569, p = 0.004) with post hoc
Dunnett’s test: GFP versus Ca2+-permeable, p = 0.838; GFP versus pore-dead, *p = 0.007; GFP versus C-tail, p = 0.985.
(F) Maximum intensity projection (3 successive confocal planes) showing examples of quadruple labeling for GFP (green), NG2 (white), Ki67 (red), and EdU (cyan)
and a merged image in animals expressing GFP or AMPAR-modifying constructs. The arrowheads point to infected Ki67+EdU+ OPC (GFP+NG2+EdU+Ki67+).
Scale bar: 10 mm.
(G) Proportion of GFP+NG2+EdU+ cells labeled for Ki67 among the GFP+ cells expressing the GFP (n = 4 mice), Ca2+-permeable (n = 5 mice), pore-dead (n = 5
mice), or C-tail (n = 5mice) constructs. Each dot represents one animal; black diamonds represent mean ± SEM for each group. One-way ANOVA (F(3, 15) = 3.47,
p = 0.043) with post hoc Dunnett’s test: GFP versus Ca2+-permeable, p = 0.067, GFP versus pore-dead, *p = 0.027, GFP versus C-tail, p = 0.53.
(H) Cumulative bar graphs showing all subpopulations of cells comprising the GFP+ population. Calculations are derived from all data on proliferation and dif-
ferentiation and are specified in Figure S4. Colored bars indicate oligodendrocyte linage cells; black bars indicate other cells.subunit triggered stronger changes in OPC proliferation than the
Ca2+-permeable mutation (Figures 4E and 4G), although electro-
physiological changes at axon-OPC synapses were similar (Fig-
ures 2D–2K). An important difference between the pore-dead
and the Ca2+-permeable mutations is that ionic conductance is858 Cell Reports 25, 852–861, October 23, 2018carried only by GluA2-lacking AMPARs in the former case but
by AMPARs composed of all subunits (including the unedited
GluA2) in the latter case. The downstream signaling cascades
may differ depending on the subunit composition, resulting in
distinct regulatory mechanisms of the OPC cell cycle.
Regulation of OPC differentiation may also involve the non-
ionotropic function of AMPARs, because expression of the
C-tail did not alter the AMPAR ionotropic function but did reduce
differentiation. AMPAR subunits interact with various binding
proteins, including GRIP, TARP, PICK, ABP, SAP97, NSF, and
the PLP-integrin-Gi complex (Harlow et al., 2015; Henley,
2003; Henley and Wilkinson, 2016), and many of these interac-
tions involve the cytoplasmic C-tails of AMPAR subunits (Henley,
2003). Expression of the C-tail may have perturbed some of
these interactions, for instance, interaction between AMPARs
and integrins, which play a key role for differentiation of the oligo-
dendroglial cells (Baron et al., 2005). It will be important to inves-
tigate the interaction partners of the GluA2 C-tail in OPCs and to
use pharmacological and genetic approaches to identifying the
molecular cascades inducing changes in OPC differentiation
by non-ionotropic mechanisms.
Proliferation and differentiation of OPCs can be modulated by
neuronal activity (Mount and Monje, 2017), and some patterns of
activity are more likely to promote proliferation, while others are
more likely to promote differentiation (Nagy et al., 2017). Synaptic
AMPARs inOPCsaregoodcandidates to transduce theeffects of
neuronal activity to OPCs. Our findings that different manipula-
tions of AMPARs in vivo result in distinct changes in proliferation
and differentiation suggest that even the same pattern of
neuronal activity may affect OPCs differently depending on the
subunit composition of postsynaptic AMPARs in OPCs.
Ourmanipulations of the establishedAMPARsignaling inOPCs
had a different outcome than elimination of AMPARs from the
onset of mouse development (Kougioumtzidou et al., 2017). Pro-
liferation anddifferentiation ofOPCs is likely controlled via several
signaling pathways (Huang et al., 2013), with AMPAR signaling
being one of them. Germline deletion of AMPARs in OPCs may
trigger compensatory mechanisms, resulting in normal prolifera-
tion and lineage progression of OPCs in the postnatal brain (Kou-
gioumtzidou et al., 2017). This is less likely in our study, because
we induced acute alterations at axon-OPCsynapses. Another dif-
ference is that we specifically targeted and analyzed the dividing
OPCs, while Kougioumtzidou et al. (2017) investigated the entire
population of OPCs (cycling OPCs and cells in the G0 phase).
AMPAR signaling may play a more prominent role in proliferating
OPCs, which have to transfer synaptic contacts to their daughter
cells (Ge et al., 2009; Kukley et al., 2008), making the effects of
AMPAR modifications more evident in these cells.
Our findings have important implications for future research
on the properties and function of AMPARs in OPCs during dis-
eases. Injury triggers trafficking of GluA2-lacking (Ca2+-perme-
able) AMPARs to the membrane in neurons, and this process
can be initiated by inflammatory molecules (Yin et al., 2012).
Similar events may take place in OPCs during inflammatory
demyelination, spinal cord injury, and other pathological condi-
tions. Therefore, investigating and manipulating properties and
downstream signaling of AMPARs in OPCs during diseases is
important for opening new therapeutic avenues.
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Maria
Kukley (maria.kukley@uni-tuebingen.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
NG2DsRedBAC transgenic mice (Ziskin et al., 2007) and C57BL/6 mice of both sexes were used in all experiments. Breeding pairs of
NG2DsRedBAC transgenic mice were originally obtained from The Jackson Laboratory (stock 008241) and C57BL/6mice were orig-
inally obtained fromCharles River. Mice were bred in house and kept in 12-12 hours of light-dark cycle; food andwater were available
ad libitum. All experiments were performed in accordance with current European Union guidelines and approved by the local gov-
ernment authorities for Animal Care and Use (Regierungspraesidium Tuebingen, State of Baden-Wuerttemberg, Germany).
METHOD DETAILS
Molecular biology
pCI-EGFPGluA2(Q583) was a gift fromRobertoMalinow (University of California, USA). The plasmids for viral production (pRetroCAG-
GFP, pCMV-gp and pCMV-vsv-g) were gifts from Fred Gage (The Salk Institute, USA). The point mutation of GluA2(Q583) to
GluA2(Q583E) was introduced using the Quick Change II XL Site-Directed mutagenesis kit (Stratagene). The primers for the point mu-
tation were (50 to 30): fwd: CTTGGGTGCCTTTATGGAGCAGGGATGCGATATTTC and rev: GAAATATCGCAT CCCTGCTCCATAAAGG
CACCCAAG. All the procedures followed the instructionmanual provided by Stratagene. To construct pRetroCAG-GluA2(Q583)-GPF,
pRetroCAG-GluA2(Q583E)-GFP and pRetroCAG-GluA2Ctail-GFP, we inserted GluA2(Q583)-GPF, GluA2(Q583E)-GFP and
GluA2Ctail-GFP by PCR amplification. PCR primers included PmeI and AgeI restriction sites for insertion into pRetroCAG-GFP. For
GluA2(Q583)-GPF and GluA2(Q583E)-GFP the primers were (50 to 30): forward TTACCGGTACGACTCACTATAGGCTAGAACTAG,
reverse TGTTTAAACCCAAGGCCTGCATGCACTGCTTTG. For GluA2Ctail-GFP the primers were (50 to 30): forward TAGCGCTA
CCGGTCGCCACCATGGTG, reverse TGGTTTAAACACCTCTACAAATGTGGTATGGCTG. The expression of all constructs was
controlled by the chicken-beta actin (CAG) promoter. All plasmids were sequenced to ensure accuracy. For retroviral production,
we used procedure described previously (Tashiro et al., 2006) with two modifications: we collected the supernatant 48 and 72 hours
after transfection and filtered the supernatant through a 0.45 mm filter (Merck). The viral titers were 108-109/ml.
Experimental groups of animals
In the majority of experiments, the following 4 groups of animals were used: (1) Animals injected with retrovirus-GFP (called ‘‘GFP’’
throughout the manuscript); (2) Animals injected with retrovirus-GluA2(R583Q)-GPF (called ‘‘Ca2+-permeable’’ throughout the
manuscript); (3) Animals injectedwith retrovirus-GluA2(R583E)-GFP (called ‘‘pore-dead’’ throughout themanuscript); and (4) Animals
injected with retrovirus-GluA2(813-862)-GFP (called ‘‘C-tail’’ throughout the manuscript). In some expetriments (see text), a fifth
group of mice was used which contained naive animals, i.e., not injected with retrovirus (non-injected). The number of animals (n)
used in each experiment is indicated in the corresponding figure legends.
Retrovirus injection
10-12 days-old NG2DsRedBAC transgenic mice were anesthetized with amixture of isoflurane and oxygen (1%–3% v/v) and fixed in
the stereotaxic frame (Stoelting, USA). The depth of the anesthesia wasmonitored by testing the reaction of themouse to a toe pinch.
For analgesia, metacam (1 mg/kg bodyweight, Boehringer Ingelheim) was injected subcutaneously before the surgery. The skin
above the skull was disinfected, a small cut was made, and xylocaine (2%, Astra Zeneca) was applied locally. Bilateral injections
of the virus into the corpus callosum were performed using the following coordinates (in mm from Bregma): anteroposterior 0.23,
mediolateral ± 0.23-0.25, dorsoventral 1.77. For each injection we used a glass micropipette containing 2.5 mL viral stock solution.
The micropipette was connected to a fast pressure application system (PDES-01D-4, NPI Electronic, Germany), and the following
parameters were used for injection: pressure 16-20 psi, application duration 60-90 ms. Subsequently, the wound was sutured
with silk (Ethicon, USA). After the surgery, mice recovered rapidly from anesthesia and were returned to their home cages with
parents.
For electrophysiological experiments we used DsRed+ mice of the NG2DsRedBAC line; for immunohistochemistry and cell count-
ing we used DsRed- littermates in order to have the red fluorescent channel available for antibody labeling.
In vivo EdU treatment
To study cell proliferation, mice were administrated with 5-ethynyl-20-deoxyuridine (EdU, Thermo Fisher) (Young et al., 2013)
intraperitoneally at a dose of 25 mg/ kg body weight. EdU was applied three times, i.e., on the third, fourth, and fifth day after the
viral injection at an interval of 24 hours.e3 Cell Reports 25, 852–861.e1–e7, October 23, 2018
Slice preparation for electrophysiology
For patch-clamp recordings, we used in total 59 mice of the age P12-17. Three to five days after the viral injection mice were anes-
thetized with a mixture of isoflurane and oxygen (3% v/v) and decapitated. The brain was dissected in the ice-cold N-methyl-D-gluc-
amine (NMDG)-based solution containing (in mM): 135 NMDG, 1 KCl, 1.2 KH2PO4, 20 choline bicarbonate, 10 glucose, 1.5 MgCl2,
and 0.5 CaCl2 (pH 7.4, 310 mOsm), gassed with carbogen (95% O2, 5% CO2). 270-300 mm thick coronal brain slices were cut in the
same solution using a Leica VT 1200S vibratome. The slices were transferred to a 32CHaas-type interface incubation chamber and
perfused with Ringer-solution containing (in mM): 124 NaCl, 3 KCl, 1.25 NaH2PO4*H2O, 2 MgCl2, 2 CaCl2, 26 NaHCO3, 10 glucose;
300 mOsm/kg; 7.4 pH; gassed with carbogen. The chamber was gradually cooled down to room temperature.
Patch-clamp recordings
At least one hour after the preparation, individual slices were transferred to a submerged recording chamber mounted on the stage of
an up-right microscope (FN-1, Nikon, Japan) equipped with infrared differential interference contrast (IR-DIC) filters and a fluores-
cence light source. The slices were kept at room temperature and superfused continuously (2 ml/min) with carbogenated Ringer
solution. OPCs were selected for recordings based on fluorescence: red fluorescence (NG2DsRed+ cells) for mice not injected
with retrovirus, or green and red double-fluorescence (GFP+NG2DsRed+ cells) for mice injected with retrovirus. Patch pipettes
were pulled from borosilicate glass capillaries (Science Products, Germany) on a vertical puller (Model PC10, Narishige, Japan).
Pipettes had resistance of 4.8-7 MOhms when filled with K-gluconate-based internal solution containing (in mM): 125 K-gluconate,
2 Na2ATP, 2 MgCl2, 0.5 EGTA, 10 HEPES, 20 KCl, 3 NaCl; 280-290 mOsm/kg; titrated to pH 7.3 with KOH. Cells were voltage-
clamped at a holding potential Vh = 80 mV with an EPC-8 amplifier (HEKA, Germany). The liquid junction potential was calculated
using the software JPCalc forWindows (Peter H. Barry, Sydney, Australia) and Vh was corrected for a13mV liquid junction potential
before seal formation. Series resistance was not compensated. After establishing the whole-cell configuration, ten depolarizing
voltage steps (increment +10 mV) were applied to each cell from Vh =80 mV, and corresponding current responses were recorded
in order to verify that the selected cell was an OPC (Kukley et al., 2010). Evoked synaptic currents were elicited with an isolated pulse
stimulator (A-M Systems, Model 2100, Science Products, Germany) using mono-polar glass electrode (resistance 5-6 MU) filled with
Ringer solution and placed at 50-150 mm from the recorded cell (Vh = 80 mV). Paired (40 ms inter-pulse interval) monophasic rect-
angular pulses of 100-250 msec duration were applied every 15 s. Trains of stimuli (20 pulses @ 100 Hz or 20 pulses @ 25 Hz) were
applied each 15 s.
For I-V curve recordings, we used a Cs-based internal solution containing (in mM): 100 CsCH3SO3H (CsMeS), 20 tetraethylammo-
nium (TEA) chloride, 20 HEPES, 10 EGTA, 2 Na2ATP, and 0.2 NaGTP; 280-290 mOsm/kg; titrated to pH 7.3 with CsOH, and a Ringer
solution containing (in mM): 119 NaCl, 2.5 KCl, 1 NaH2PO4*H2O, 1.3 MgCl2, 2.5 CaCl2, 26.2 NaHCO3, 11 glucose; 300 mOsm/kg;
7.4 pH; gassed with carbogen. Spermine (Sigma, 100 mM) was included into the internal solution in all recordings of evoked EPSCs
in order to test for the presence of Ca2+-permeable AMPA receptors in OPCs. Vh was corrected for a 7 mV liquid junction potential
before seal formation. The cells were held at different potentials (90,40, 0, +20, and +40 mV) and 10-15 sweeps were recorded at
each potential.
When recording the synaptic currents, we applied a voltage step of 5 mV at the beginning of each sweep to monitor series
resistance. Whole-cells currents in response to voltage steps were low-pass filtered at 10 kHz and digitized with a sampling
frequency of 20 kHz (ITC-18, HEKA Instruments Inc, USA). All recordings of synaptic currents were low-pass filtered at 1 kHz and
digitized with a sampling frequency of 10 kHz. Data acquisition was performed using Recording Artist (Rick Gerkin, Arizona State
University, USA) running under Igor Pro 6.3 (WaveMetrics, Lake Oswego, USA). All recordings of evoked synaptic currents were
performed in the presence of NMDA-receptor antagonist CPP (10 mM, Tocris) and GABAA receptor antagonist gabazine (5 mM,
Sigma). In some experiments, TTX (0.5 mM, Abcam) or CNQX (10 mM, Abcam) was applied at the end of the recording. All drugs
were dissolved in Ringer solution and applied via the bath. All patch-clamp recordings were performed at room temperature.
Immunohistochemistry
For MBP staining, C57BL/6 mice were sacrificed at P9, P10, P11, P12, P15, and P18. For all other stainings, mice were sacrificed
5 days after the retroviral injection. The brain was removed, and 350-400 mm thick coronal slices were cut using the Leica VT
1200S vibratome in the solution of the following composition (in mM): 87 NaCl, 2.5 KCl, 1.25 NaH2PO4*H2O, 7 MgCl2, 0.5 CaCl2,
25 NaHCO3, 25 glucose, 75 sucrose or NMDG-based solution. The slices were fixed overnight at 4
C in 4% paraformaldehyde, dis-
solved in 10 mM phosphate-saline buffer (PBS). Subsequently, thick slices were washed, embedded into Agar and re-sectioned in
PBS to 30 mm thickness using amicrotome (HM650V, Thermo Scientific). All 30 mm thick sliceswere inspected visually for quality and
for presence of GFP-expressing cells using an epi-fluorescencemicroscope (Axio Imager Z1m, Zeiss, Germany). Slices which did not
contain green cells or appeared damaged were discarded. From the remaining pool, 4-12 slices per mouse were selected and used
for immunohistochemistry and cell counting. The stainings were performed on 30 mm free floating slices in multi-well plates, or (in few
cases) mounted on glass-slides. For antigen retrieval, the slices were incubated in 10mMcitric acid (pH = 6.0) at 37C. After washing,
we applied blocking solution containing: 0.1 M Tris-buffer saline (TBS), 3%–5% Albumin Fraction V (Roth), and 0.2%–0.5% Triton-X
(Roth), at 37C for 1 hour. Slices were incubated with primary antibody overnight in blocking solution. The following primary anti-
bodies were used: rabbit or guinea pig anti-NG2 (1:500, gift from Bill Stallcup, Burnham Institute, La Jolla, USA), mouse anti-APC
(1:250, Ab-7, CC-Calbiochem), rabbit anti-Cleaved-Caspase-3 (1:500, Cell Signaling Technology), chicken anti-GFP (1:500, Abcam),Cell Reports 25, 852–861.e1–e7, October 23, 2018 e4
rat anti-MBP (1:125, Abcam), mouse anti-ki67 (1:500, BD PharMingen), mouse anti-MAG (1:1000 Santa Cruz Biotechnology).
Detection was performed using the following secondary antibodies: goat anti-rabbit Alexa Fluor 568 (1:500, Invitrogen), goat anti-
rabbit Cy5 (1:500, Dianova), goat anti-rabbit Alexa Fluor 405 (1:150, Invitrogen), goat anti-guinea pig Alexa Fluor 633 (1:500, Invitro-
gen), goat anti-mouse Alexa Fluor 555 (1:500, Invitrogen), donkey anti-chicken FITC (1:1000, Dianova), goat anti-chicken Alexa Fluor
488 (1:500, Invitrogen) or goat anti-rat biotin-SP (1:200, Dianova) followed by streptavidin-Cy3 (1:200, Dianova). Secondary anti-
bodies were applied for 3 hours at 37C. For EdU visualization, the protocol recommended by Thermo Fisher Scientific was used.
Diamidino-2-phenylindole dihydrochloride (DAPI, 0.2 mg, Sigma) was used for counterstaining of the cell nuclei.
Image acquisition
A confocal LSM 710 system (Zeiss, Germany) was used for image acquisition. Images containing corpus callosumwere acquired and
saved as z stacks with 16 bit pixel depth. Each z stack was 6-18 mm thick and consisted of 6-18 z-slices at a step size of 1 mm. Each
layer of a z stack was acquired as a tile-scan (vertical x horizontal: 3 3 7 or 2 3 7 images), where each tile was 512 3 512 pixels in
size. Pixel size was usually 0.4153 0.415 mm, with exception of images shown in Figures S3B and S3C, where pixel size was 0.0333
0.033 mm. Each tile-scan represented a quadruple-channel fluorescence image, where channels were acquired sequentially in ZEN
software using 40x oil-immersion objective (NA = 1.3). For images shown in Figures S3B and S3C we used 63x objective (NA = 1.4).
The following excitation laser lines and emission detection ranges were used: for DAPI excitation 405 nm, emission 414-490 nm; for
FITC excitation 488 nm, emission 497-556 nm; for Alexa-555, Alexa-568 or Cy3 excitation 561 nm, emission 569-633 nm; for Alexa-
633 or Alexa-647 excitation 633 nm, emission 650-740 nm. The beam splitters for each dye matched the excitation laser lines. The
pinhole was set to 1.07-1.42 airy units and adjusted such that the optical section for each channel was 1.2 mm. The exception are the
images shown in Figure 1C, where we used 10x objective and optical section was 12.3 mm. Laser power, detector gain, and offset
were adjusted such that in the final scan (average of 2 frames) a good signal to background noise ratio was achieved. For visualiza-
tion, images presented in the figures were adjusted for brightness/contrast in ImageJ (NIH, USA), as follows: Figure 1F, brightness of
GFP staining; Figure 1I, brightness and contrast for NG2 and CC1 staining; Figure 1J, brightness and contrast for CC1; Figure 3B,
brightness and contrast for NG2 and CC1 staining for pre-OL; Figure 3H, brightness for NG2 staining; Figure 3J, brightness and
contrast for GFP staining; Figure 4B, brightness of EdU staining for GFP group; Figure 4F, brightness for GFP staining in GFP group;
Figure S2E, brightness for GFP; Figure S2F, brightness for GFP; Figures S3B and S3C, brightness and contrast for GFP (green;
without antibody labeling) and GFP staining (red; non-permeabilized conditions); Figure S3G, brightness and contrast for Caspase3.
QUANTIFICATION AND STATISTICAL ANALYSIS
Analysis of electrophysiology data
Only recordings where the offset drift by the end of the experiment was smaller than ± 5 mV, and the change of the series resistance
was < 30% relative to the original value were considered for the analysis. The series resistance was between 20 and 40 MU.
Analysis of evoked EPSCs, I-V curve, and paired-pulse ratio
Analysis of evoked EPSCs was performed using custom-written macros in IgorPro. Stimulus artifacts were removed using the
following procedure: sweeps containing failures (absence of postsynaptic response) after the first stimulus, or sweeps recorded
in the presence of TTX or CNQX, were averaged and the segment of the averaged sweep from time-point of stimulation to last point
before the second stimulus was cut out, duplicated and concatenated with itself. The resulting sweep was subtracted from each
recorded sweep.
Tomeasure the EPSC amplitude (after first or second pulse), we used the following procedure: For each recorded sweep the base-
line was adjusted to the 100-ms segment immediately preceding the stimulation; the peak-center of each event was determined
as the time-point at which the first derivative of the sweep crossed zero; the amplitude values of the current in the peak-center
and in 4 points around it (2 points to the right and 2 points to the left) were averaged, and the resulting value was taken as current
amplitude. The threshold for event detection was determined individually for each recorded sweep and was equal to three times
the standard deviation of the noise. In case several EPSCs occurred after a given stimulus, care was taken to measure the amplitude
of the first event.
Although we used paired-pulse stimulation in all experiments, in order to generate the I-V curve we considered only the EPSCs
occurring after the first pulse. The amplitudes of all recorded sweeps (10 to 15) at a given holding potential (90, 40,
0, +20, +40 mV, and back to 90 mV) were measured as described above, and averaged. The resulting averages were used to
generate the I-V curve in each cell. To calculate the rectification index, the average value of the EPSC amplitude at +40 mV was
divided by the average value of the EPSC amplitude at 90 mV.
To determine the paired-pulse ratio, the average amplitude value of the EPSC occurring after the second pulse was divided by the
average amplitude value of the EPSC occurring after the first pulse at a holding potential of 90 mV.
Analysis of delayed EPSCs
To study the quantal amplitude of synaptic currents in OPCs, we analyzed the delayed EPSCs occurring in OPCs after the train stim-
ulation of callosal axons with 20 pulses at 25 or 100 Hz. The delayed EPSCs were defined as those with an onset of > 10 ms after the
last stimulus of the train. In each recorded cell we collected the delayed EPSCs in 20-160 sweeps of 1.73-2.3 s length each. The
EPSCs were detected using a deconvolution-based algorithm (Pernı´a-Andrade et al., 2012) in FBrain, a customized program runninge5 Cell Reports 25, 852–861.e1–e7, October 23, 2018
under IgorPro 6 (WaveMetrics, Lake Oswego, USA). FBrain was kindly provided by Peter Jonas Lab (IST, Klosterneuburg, Austria).
Additional digital high-pass (10 Hz) and Notch (50 ± 0.5 Hz) filtering was applied to the recorded sweeps in FBrain before the analysis.
The deconvolution trace was passed through a digital band-pass filter at 0.001 to 200 Hz. The event detection template had a rise-
time of 0.5 ms, a decay time constant of 4 ms, and amplitude of 3 pA. The event detection threshold (q) was set to 4.2 times the
standard deviation of a Gaussian function fitted to the all-point histogram of the deconvolved trace (Pernı´a-Andrade et al., 2012).
All events detected by the algorithmwere inspected visually, and those eventswhich clearly did not show kinetics of typical excitatory
postsynaptic currents (i.e., fast rise and exponential decay) were manually removed. The subsequent analysis was performed using
custom-written macros in IgorPro.
Cumulative probability histogram of the amplitude of delayed EPSCs
The following procedure was used: (1) The amplitude of all delayed EPSCs was measured in each cell as described above; (2) 67
delayed EPSCs were randomly selected from each cell using the StatsSample procedure in IgorPro; (3) the amplitude distribution
of randomly selected events was compared to the amplitude distribution of all events within a given cell using the Kolmogorov-Smir-
nov test in IgorPro to ensure that the two distributions were similar, and the pool of randomly selected events was representative of
the whole population of events. In case the two distributions were different, the random selection was automatically repeated until no
difference was found between the distributions; (4) in each cell, steps (2)-(3) were repeated 100 times; (5) for each of the 100 trials, the
randomly selected events from all cells within a given experimental group were pooled to generate an EPSCs amplitude distribution
per experimental group; (6) for each of the 100 trials this new amplitude distribution of the events in a group of animals expressing one
of the GluA2-subunit modifying constructs was compared to the GFP group using the Kolmogorov-Smirnov test in IgorPro. In
selected trials, the comparison was repeated using SPSS.
For data presentation in Figure 2H and Figure S1E, we chose one representative example from the 100 random selection trials for
each experimental group. The bin size for cumulative probability histogramswas 0.5 pA, and each histogramwas normalized to prob-
ability density using built-in function in IgorPro.
Non-stationary fluctuation analysis (NSFA)
To estimate the single channel conductance of synaptic AMPARs in OPCs we performed peak-scaled non-stationary fluctuation
analysis (Hartveit and Veruki, 2007). In each cell, the delayed EPSCs were examined visually and only the events with smooth
rise- or decay phase were selected for NSFA. Spearman’s rank-order correlation test was applied to verify that there was no drift
in the peak amplitude, rise-time, or decay-time of the events during the time-course of each experiment. In addition, we also verified
that there was no correlation between rise-time and decay-time constant (Hartveit and Veruki, 2007). If any of the indicated corre-
lations was found, the cell was excluded from the NSFA. On average, 13 events (range 7-17) were selected randomly from each
cell (n = 6 cells for GFP, n = 5 for ‘‘Ca2+-permeable,’’ n = 7 cells for ‘‘pore-dead,’’ and n = 8 for ‘‘C-tail’’), and were pooled within
each experimental group. This resulted in, on average, 82 events (range 57-94) included into the NSFA within each experimental
group. The events were aligned on the point of steepest rise, which corresponds to the location of the minimum value of the first
time derivative of the event waveform. The mean waveform was calculated from these events and the amplitude of the mean wave-
form was scaled to the amplitude of each individual event. Subsequently, the scaled mean waveform was subtracted from each in-
dividual event, resulting in the noise component for each event, from which the variance was calculated. The background variance
was estimated from the segment of the trace before the onset of each event, and was subtracted. The ensemble background-sub-
tracted variance was calculated as an average of variances of all events. The mean amplitude wave was binned into 18 bins, and the
corresponding values of the variance wave were then obtained in accordance with this binning (Hartveit and Veruki, 2007). Different
number of bins was also tested, but varying the number of bins did not affect the results. Finally, the values of variance were plotted
versus the corresponding values of the mean current amplitude. The resulting variance-mean relationship was fitted with the
following parabola function in IgorPro:
d2ðIÞ= i  I­I2N+ dbgr2
where d2(I) is the variance; i is the (weighted) estimate of a mean single channel current; N is average number of channels opened
at the peak, and dbgr
2 is the background variance. The single-channel conductance (g) of synaptic AMPAR was calculated from
the single-channel current i as:
g= i=E
where E is the driving force for AMPAR-mediated EPSC, which is 80 mV in our study.
Notably, because we used the peak-scaling method for NSFA, the information on the total number of available channels is lost
(Hartveit and Veruki, 2007), the parameter N has no meaning, and is not further analyzed/presented in our study.
The random selection, the pooling process, and all subsequent procedures described above were repeated 100 times for each of
our 4 experimental groups, and by 4 researchers, resulting in total of 400 random selections and pooling per experimental group.
All routines for NSFA were custom programmed and were based on the code presented in the supplementary material of Hartveit
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Estimation of the fraction of rectifying AMPARs (FRR) based on rectification measurements
To obtain the FFR, we used the equation developed by Stubblefield and Benke (Stubblefield and Benke, 2010), which allows for esti-
mation of the FRR based on rectification measurements. Their rectification indices were calculated as a ratio of EPSC amplitudes
recorded at70 mV and at +40 mV. Tomatch their approach, we took the inverse of our RI values (1/RI) from Figure 2E and adjusted
their equation to model our results as follows:
FFR= ð1 1=RI  F3Þ=1=RI  ðF1 F3Þ;
where F1 is the maximal block of inwardly rectifying receptors (EPSC at +40 mV/ EPSC at 90mV), extrapolated to be 0.035 (based
on (Rozov et al., 1998; Stubblefield and Benke, 2010)). F3 is the value for linear relationship (F3 = 40/90 = 0.444). This analysis
assumes that there is no change in presynaptic function (c.f. Figures S1F and S1G and Figures S3D–S3E).
Cell counting
We counted GFP-labeled infected cells in z stack images using ImageJ Cell Counter plugin (NIH, USA). No contrast or brightness
adjustment wasmade in any of the images, but background subtraction was applied to the green channel before counting. The back-
ground fluorescence wasmeasured using the linear ‘plot profile’ function in ImageJ and the resulting value was subtracted from each
pixel of the original image. The ventral and dorsal borders of corpus callosum were identified based on the CC1 or NG2 and DAPI
staining. For counting, in each coronal slice we outlined the area of the corpus callosum approximately 500-850 mm laterally on
each side from the midline. Thus, the ROI spanned 1-1.4 mm along the mediolateral axis of the corpus callosum and avoided cells
in the vicinity of lateral ventricles. Only cells within the ROI and cells whose nucleus wasR 50% within its borders were included in
the analysis. Cells were counted in 4-12 slices from each mouse and the counts within one animal were summed, resulting in 29 to
486 GFP+ cells per animal. OPCs were identified as GFP+NG2+CC1- cells, pre-myelinating oligodendrocytes as GFP+NG2+CC1+
cells, and myelinating oligodendrocytes as GFP+NG2-CC+ cells. To avoid bias, in randomly selected experiments the counting
was repeated by one or two additional investigators blind to the experimental group of animals. The differences in counts were minor
and did not affect the final results.
Statistics
All data acquisition was randomized (animals for viral injections, cells during patch-clamp experiments). Throughout the study we
made all efforts to avoid pseudoreplications, both when performing experiments in slices and in vivo. The exact number of cells
and animals used in each experiment is given in the figure legends.
Statistical analysis was performed using SPSS, including tests for homoscedasticity and normal distribution. If the datasets had
normal distributions and equal variances, one-way ANOVA with post hoc Dunnett’s or Bonferroni (Figures 3E–3G) test was used.
If the datasets had normal distributions but unequal variances, one-way ANOVA with post hoc Games-Howell test was used. If
the datasets were not normally distributed, Kruskal-Wallis with post hoc Dunn’s test was used. In all Figures, except the Figures
3E–3G, we were interested only in the comparison between the experimental groups with AMPAR-manipulation and the GFP control
group. Therefore, the p values in the Figure Legends are shown only for these comparisons. To compare values of rectification index
and paired-pulse ratio between cells in non-injected and GFP expressing animals, we tested the datasets for normal distribution and
used the 2-tailed Student’s t test. To compare cumulative probability histograms of the amplitude of the delayed EPSCs between
control (GFP) and each experimental group (‘‘Ca2+-permeable,’’ ‘‘pore-dead,’’ or ‘‘C-tail’’), 100 trials of random selections of
events were performed and compared in IgorPro with Kolmogorov-Smirnov test as described above. Comparison of the GFP and
‘‘Ca2+-permeable’’ groups showed that the two distributions were different in all 100 trials therefore, we considered the difference
between these two distributions statistically significant. Comparison of the GFP and ‘‘pore-dead’’ groups showed that the two dis-
tributions were different in 98 out of 100 trials therefore, we considered the difference between these two distributions statistically
significant. Comparison of the GFP and ‘‘C-tail’’ groups showed that the two distributions were different in only 46 out of 100 trials;
therefore, we considered the difference between these two distributions not statistically significant. To report the corresponding
p values in the figure, we used the Kolmogorov-Smirnov test in SPSS. For all statistical comparisons, significance level was set
at p < 0.05. Statistically significant differences are indicated by p values in the figure legends. * represents p% 0.05, ** represents
p% 0.01, and *** represents p% 0.001. For graphs, each point represents an individual data point (cell or animal) and the diamond
represents the mean ± SEM. Data in the text report mean ± SEM.
DATA AND SOFTWARE AVAILABILITY
The datasets generated and analyzed in the current study and custom-written macros for electrophysiological analysis are available
from the lead author upon request.e7 Cell Reports 25, 852–861.e1–e7, October 23, 2018
